Zhejiang Tianyu Pharmaceutical Co., Ltd.

Form 483 issued November 29, 2024 · Taizhou, China

Inspection
Nov 21 – Nov 29, 2024
Observations
2
Pages
4
FEI number
3010972581

In short: On November 29, 2024, FDA issued a Form 483 with 2 observations to Zhejiang Tianyu Pharmaceutical Co., Ltd. in Taizhou, Zhejiang (FEI 3010972581) after an inspection that ran Nov 21 – Nov 29, 2024. The investigators were Alan A. Rivera and Pratik S. Upadhyay. Most observations concern laboratory controls and facilities & equipment; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and facilities & equipment account for 2 of 2 observations.

Laboratory controls1
Facilities & equipment1

Most cited: 21 CFR 211.160 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to establish an impurity profile for…

  2. 02

    Failure to clean equipment at appropriate intervals to prevent build-up and carryover of contaminants and degradants…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Zhejiang Tianyu Pharmaceutical Co., Ltd.?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and facilities & equipment. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Zhejiang Tianyu Pharmaceutical Co., Ltd.?

Alan A. Rivera and Pratik S. Upadhyay are named on this Form 483, for the inspection of Nov 21 – Nov 29, 2024. Each investigator has a profile showing what they cite most.

When was Zhejiang Tianyu Pharmaceutical Co., Ltd. inspected by FDA?

The inspection ran Nov 21 – Nov 29, 2024, and the Form 483 is dated November 29, 2024.

How do I get the full Form 483 for Zhejiang Tianyu Pharmaceutical Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free